Team
Thioredoxin Systems AB is a growing organisation, supported by an expert advisory board, dedicated to the development of EbsArgent® as a new solution to antimicrobial resistance.
BOARD OF DIRECTORS
Mikael Lönn, MD
CHAIRMAN OF THE BOARD
A seasoned physician and entrepreneur with a proven track record in the healthcare and life sciences sectors. Mikael brings extensive experience in financial investments and active board leadership, guiding both start-up and established companies to success. His strategic insights and leadership have driven innovation, growth, and value creation across the industry. As a dedicated advocate for advancing healthcare solutions, he continues to play a pivotal role in fostering the development of transformative technologies and therapies.
Gisela Sitbon, PhD
BOARD MEMBER
With a PhD in Medical Sciences and over 25 years of senior leadership experience, Gisela is a recognised expert in the life sciences field. Her career spans executive management, entrepreneurship, and board leadership, where she has contributed to the development and commercialisation of diagnostic and therapeutic solutions. Gisela's expertise includes business development, operational strategy, and navigating the complexities of the life sciences ecosystem, making her an invaluable leader in driving impactful change and innovation.
Mohamad Takwa, PhD
BOARD MEMBER & BUSINESS ADVISOR
With a PhD in Biotechnology and 20 years of experience in the life sciences field, he has built a track record of translating cutting-edge science into products and companies. He has co-founded, led and exited multiple biotech and MedTech ventures. His expertise spans integrating innovation with business strategy, driving complex projects to success, and fostering cross-disciplinary collaborations. His contributions to diagnostics, therapeutics, and industrial biotechnology have consistently delivered high-impact solutions.
